Neuropathology in mice expressing mouse alpha-synuclein.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alpha-synuclein (αSN) is genetically and neuropathologically linked to Parkinson's disease (PD).
• The disease-causing potential of wildtype mouse αSN (mαSN) in vivo was previously unreported.
• This study investigates the effects of elevated mαSN in the central nervous system.

Purpose of the Study:

• To determine if increased expression of wildtype mαSN induces neuropathological and behavioral changes in mice.
• To compare the effects of mαSN with human wildtype and mutant αSN in transgenic models.

Main Methods:

• Generation of transgenic mouse lines expressing mαSN in central neurons at elevated levels.
• Analysis of neuropathology, including ubiquitin immunopathology, αSN phosphorylation, and axonal/myelin integrity.
• Assessment of behavioral phenotypes, focusing on motor abnormalities and muscle weakness.

Main Results:

• Transgenic mice expressing high levels of mαSN exhibited pronounced ubiquitin immunopathology in the spinal cord and brainstem.
• Ser129-phosphorylated αSN aggregates and axonal degeneration were observed, mirroring changes seen in mice expressing human αSN.
• Unlike human αSN models, mαSN mice showed only end-stage phenotypic alterations coinciding with neuropathology, not early-onset motor deficits.

Conclusions:

• Elevated wildtype mαSN expression drives significant neuropathological changes in murine neurons.
• These changes are pathologically similar to those induced by human αSN, despite the absence of early-onset behavioral deficits.
• This research provides insights into the role of αSN levels in Parkinson's disease pathogenesis.